Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis

被引:36
|
作者
Möller, B
Kukoc-Zivojnov, N
Kessler, U
Rehart, S
Kaltwasser, JP
Hoelzer, D
Kalina, U
Ottmann, OG
机构
[1] Univ Frankfurt Klinikum, Med Klin 3, Ctr Rheumat Dis, Lab B2 19 20, D-64686 Lautertal, Germany
[2] Univ Frankfurt Klinikum, Dept Internal Med, D-64686 Lautertal, Germany
[3] Univ Frankfurt Klinikum, Dept Arthrit Surg, D-64686 Lautertal, Germany
关键词
rheumatoid arthritis; IL-18; fibroblast-like synoviocytes; PBMC; cytokines;
D O I
10.1093/rheumatology/40.3.302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate the expression of and monokine induction by interleukin 18 (IL-18; also called interferon-gamma inducing factor, IGIF), in peripheral blood mononuclear cells (PBMC) and cultured synoviocytes from rheumatoid arthritis (RA) patients. Methods. We carried out IL-18 Western blotting and semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) of cytokines in PBMC [IL-18, IL-1 beta and tumour necrosis factor alpha (TNF-alpha)] and long-term cultured fibroblast-like synoviocytes (FLS) [IL-18, IL-1 beta, TNF-alpha, IL-6, interferon gamma (INF-gamma) and [granulocyte-macrophage colony stimulating factor (GM-CSF)] from RA patients and controls. FLS were isolated from RA synovial membranes (FLSSM) and RA synovial fluids (FLSSF), osteoarthritis (OA) FLSSM and FLSSF: from spondyloarthropathy patients. FLS were characterized by fluorescence-activated cell sorting of the FLS. PBMC and FLS from RA patients and control subjects were stimulated with recombinant human IL-18 and IL-1 beta (rHuIL-18/rHuIL-1 beta), and TNF-alpha, IL-1 beta and MMP-1 were measured by ELISA in supernatants. Results. Constitutive expression of IL-18 mRNA was significantly reduced whereas that of TNF-alpha was enhanced in RA PBMC. Persistent low expression of IL-18, TNF-alpha, GM-CSF and IL-1 beta was observed in RA and OA FLSSM as well as spondyloarthropathy FLSSF. In contrast, high constitutive expression of IL-18 in FLS (CD90/Thy-1- and CD54-positive, CD14- and CD86-negative), accompanied by persistent high levels of TNF-alpha, GM-CSF and IL-1 beta expression, was restricted to synovial fluid-derived FLS obtained from RA patients. IFN-gamma was not detectable in any culture, but IL-6 mRNA was equally expressed in all FLS cultures. rHuIL-18 was effective in stimulating TNF-alpha and IL-1 beta secretion in PBMC from healthy controls, but failed to stimulate TNF-alpha and IL-1 beta secretion from PBMC in 11 of 12 RA patients, and all FLS cultures. rHu-IL-1 beta, but not rHu-IL-18, induced interstitial collagenase (MMP-1) in FLS. Conclusions. Persistent high production of proinflammatory cytokines in RA-FLSSF may be relevant for chronic progression in RA synovitis. Levels of TNF-alpha and IL-1 beta expression are increased in RA-FLSSF, but are independent of IL-18. The pathological function of enhanced IL-18 expression in RA-FLSSF remains to be further elucidated.
引用
收藏
页码:302 / 309
页数:8
相关论文
共 50 条
  • [11] Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts
    Y. Lu
    W.-J. Wang
    J.-H. Leng
    L.-F. Cheng
    L. Feng
    H.-P. Yao
    Inflammation Research, 2008, 57 : 260 - 265
  • [12] Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts
    Lu, Y.
    Wang, W. -J.
    Leng, J. -H.
    Cheng, L. -F.
    Feng, L.
    Yao, H. -P.
    INFLAMMATION RESEARCH, 2008, 57 (06) : 260 - 265
  • [13] Lack of association between interleukin-18 polymorphisms and rheumatoid arthritis
    Justina Fariasa, Ticiana Della
    do Canto, Luisa Matos
    Medeiros, Mayara Delagnelo
    Rodrigues Sereia, Aline Fernanda
    Fernandes de Carlos Back, Lia Kubelka
    de Mello, Filipe Martins
    Zimmermann, Adriana Fontes
    Pereira, Ivanio Alues
    Netto Muniz, Yara Costa
    Marrero, Andrea Rita
    de Souza, Iliada Rainha
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (02) : 199 - 205
  • [14] Heterogeneity of response of rheumatoid synovium cell subsets to interleukin-18 in relation to differential interleukin-18 receptor expression
    Kawashima, M
    Miossec, P
    ARTHRITIS AND RHEUMATISM, 2003, 48 (03): : 631 - 637
  • [15] Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
    Gualberto Cardoso, Pablo Ramon
    Diniz Lopes Marques, Claudia
    de Melo Vilar, Kamila
    Dantas, Andrea Tavares
    Branco Pinto Duarte, Angela Luzia
    Pitta, Ivan da Rocha
    Galdino da Rocha Pitta, Maira
    Barreto de Melo Rego, Moacyr Jesus
    AUTOIMMUNE DISEASES, 2021, 2021
  • [16] Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis
    Takei, Satoko
    Hoshino, Tomoaki
    Matsunaga, Kazuko
    Sakazaki, Yuki
    Sawada, Masanori
    Oda, Hanako
    Takenaka, Shin-ichi
    Imaoka, Haruki
    Kinoshita, Takashi
    Honda, Seiyo
    Ida, Hiroaki
    Fukuda, Taka-aki
    Aizawa, Hisamichi
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (02)
  • [17] Interleukin-18 gene polymorphisms and rheumatoid arthritis: A meta-analysis
    Ji, Jong Dae
    Lee, Won Jin
    GENE, 2013, 523 (01) : 27 - 32
  • [18] Interferon-γ-inducing activity of interleukin-18 in the joint with rheumatoid arthritis
    Yamamura, M
    Kawashima, M
    Taniai, M
    Yamauchi, H
    Tanimoto, T
    Kurimoto, M
    Morita, Y
    Ohmoto, Y
    Makino, H
    ARTHRITIS AND RHEUMATISM, 2001, 44 (02): : 275 - 285
  • [19] Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis
    Satoko Takei
    Tomoaki Hoshino
    Kazuko Matsunaga
    Yuki Sakazaki
    Masanori Sawada
    Hanako Oda
    Shin-ichi Takenaka
    Haruki Imaoka
    Takashi Kinoshita
    Seiyo Honda
    Hiroaki Ida
    Taka-aki Fukuda
    Hisamichi Aizawa
    Arthritis Research & Therapy, 13
  • [20] Interleukin-18 as an in vivomediator of monocyte recruitment in rodent models of rheumatoid arthritis
    Jeffrey H Ruth
    Christy C Park
    M Asif Amin
    Charles Lesch
    Hubert Marotte
    Shiva Shahrara
    Alisa E Koch
    Arthritis Research & Therapy, 12